MRK Merck

$114.02 -1.30%

Healthcare · Pharmaceutical Preparations

Merck (MRK) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $281.6 billion. Shares last traded at $114.02, 8.9% below their 52-week high. Over the past year the stock is up 39.0%. MRK trades at a price-to-earnings ratio of 15.43, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 28.1%, above the peer median of -0.1%. Revenue grew 1.3% year over year. The shares yield 4.3% in dividends.

Market Cap

$281.6B

Shares Out

2.47B

EPS (TTM)

$10.14

P/E Ratio

11.24

P/S Ratio

4.33

P/B Ratio

6.14

Dividend / Share

$4.90

Dividend Yield

4.30%

52-Week High

$125.10

52-Week Low

$76.67

Volume

537,794

Avg Vol (3m)

382,609.127

Performance

-4.64%

+2.38%

-1.60%

+13.65%

YTD

+7.07%

+39.05%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

43.97

SMA (50)

$115.75

SMA (200)

$105.06

Price vs SMA50

-1.50%

Price vs SMA200

+8.53%

ATR (14)

$3.12

Financials

Revenue

$65.0B

Net Income

$18.3B

Gross Margin

—

Operating Margin

—

Net Margin

28.1%

Return on Equity

39.8%

Return on Assets

14.2%

Current Ratio

1.30

Debt / Equity

1.02

Revenue Growth (YoY)

+1.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-1.72	2026-05-04
FY 2025	$7.28	2026-02-24
Q3 2025	$6.08	2025-11-05
Q2 2025	$3.77	2025-08-05
Q1 2026	$2.01	2026-05-04
FY 2025	$6.74	2026-02-24

Full earnings history →

Pharmaceutical Preparations peers

MRK vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

15.43 / 16.82 med

-8% discount

P/S vs peers

4.33 / 3.54 med

+22% premium

Net margin vs peers

28.1% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.